75 results on '"Magallares, B."'
Search Results
2. AB0880 PROGNOSTIC SIGNIFICANCE OF DISEASE DURATION, AGE, AND PERSISTENT INFLAMMATION IN AORTIC VALVE DEGENERATIVE LESIONS AMONG PATIENTS WITH SPONDYLOARTHRITIS
3. AB1711 DIAGNOSTIC ACCURACY OF SERUM CALPROTECTIN DETECTION TECHNIQUES (CLIA AND EIA) AS BIOMARKERS FOR DISEASE ACTIVITY IN JUVENILE IDIOPATHIC ARTHRITIS
4. AB1354 SPANISH NATIONAL MULTICENTER REGISTRY OF PREGNANCY IN SYSTEMIC AUTOINMUNE RHEUMATIC DISEASES
5. AB0810 SEROLOGICAL AND/OR IMMUNOLOGICAL BIOMARKERS INFLUENCE THE CLINICAL PHENOTYPE OF EXTRAGLANDULAR MANIFESTATIONS IN PRIMARY SJÖGREN’S SYNDROME
6. POS1451 THE PROGNOSTIC VALUE OF THE IMMUNOHISTOCHEMICAL STAINING OF THE MINOR SALIVARY GLAND BIOPSY IN SJOGREN’S SYNDROME: 3 YEARS FOLLOW UP
7. AB0811 NAILFOLD CAPILLAROSCOPY FINDINGS IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES AND ITS ASSOCIATION TO AUTOANTIBODIES: A CASE-CONTROL STUDY
8. POS0082 APPLICATION OF THE NEW 2022 ACR/EULAR CLASSIFICATION CRITERIA FOR CALCIUM PYROPHOSPHATE DEPOSITION DISEASE (CPPD) IN A COHORT OF PATIENTS DIAGNOSED WITH SERONEGATIVE RHEUMATOID ARTHRITIS
9. POS1223 ASSOCIATION BETWEEN NAILFOLD VIDEOCAPILLAROSCOPY FINDINGS AND SKL-6 LEVELS IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES–RELATED INTERSTITIAL LUNG DISEASE
10. AB1008 TIME, DURATION AND ORDER OF APPEARANCE OF EXTRA-ARTICULAR MANIFESTATIONS IN SPONDYLARTHRITIS: CLINICAL RISK FACTORS
11. POS0120 SAFETY AND EFFICACY OF SUBCUTANEOUS (S.C.) DOSE IANALUMAB (VAY736; ANTI-BAFFR mAb) ADMINISTERED MONTHLY OVER 28 WEEKS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
12. AB0633 PREGNANCY IN SYSTEMIC LUPUS ERYTHEMATOSUS: DESCRIPTION AND COMPARISON OF COMORBIDITIES WITH OTHER SYSTEMIC AUTOIMMUNE DISEASES FROM A RHEUMATOLOGY PREGNANCY CLINIC
13. AB0630 PREGNANCY IN AUTOIMMUNE DISEASES: THE IMPACT OF PREGNANCY PLANNING ON REPRODUCTIVE OUTCOMES IN A MULTIDISCIPLINARY PRECONCEPTION OUTPATIENT CLINIC
14. AB1150 ORDER OF APPEARANCE OF PSORIASIS AND ARTHRITIS SYMPTOMS IN PSORIATIC ARTHRITIS: COMPARATIVE STUDY OF A RETROSPECTIVE COHORT
15. AB1444 BIOMARKERS IN JUVENILE IDIOPATIC ARTHRITIS: DESCRIPTION OF GROUPS WITH DIFFERENT DEGREES OF DISCREPANCY BETWEEN SERUM CALPROTECTIN AND C-REACTIVE PROTEIN.
16. AB0716 CLINICAL FACTORS ASSOCIATED WITH VASCULAR COMPLICATIONS (ANEURYSMS, THROMBOSIS, DISSECTION OR SURGERY) IN PATIENTS WITH GIANT CELL ARTERITIS
17. AB0681 HISTORY OF ABORTION AND MULTIPARITY IN SYSTEMIC AUTOIMMUNE DISEASES: RESULTS FROM A MULTIDISCIPLINARY PREGNANCY CLINIC (GYNECOLOGY, RHEUMATOLOGY AND NEPHROLOGY)
18. AB1237 COMPARISON BETWEEN ENZYME IMMUNOASSAY AND CHEMILUMINESCENCE TO DETERMINE THE CONCENTRATION OF SERUM CALPROTECTIN AND ITS ASSOCIATION WITH CLINICAL VARIABLES IN PEDIATRIC RHEUMATOLOGY.
19. POS0827 HEPATOTROPIC VIRUSES WITH HIGHER RHEUMATOID FACTOR, BUT NOT RHEUMATIC DISEASES LINK TO PREVALENT CRYOGLOBULINEMIA. CORRELATION OF CLINICAL AND SEROLOGICAL MARKERS WITH ETIOLOGICAL CAUSES
20. AB0804 ONE YEAR FOLLOW-UP SAFETY AND EFFICACY RESULTS OF VACCINATION PROTOCOL FROM A RHEUMATOLOGY CLINIC
21. AB0129 IL-6R GENETIC VARIANTS AS PREDICTORS OF CLINICAL RESPONSE TO TOCILIZUMAB IN RHEUMATOID ARTHRITIS PATIENTS
22. AB0666 PROGNOSTIC VALUE OF SERUM KREBS VON DEN LUNGEN-6 GLYCOPROTEIN CIRCULATING LEVELS IN COVID-19 PNEUMONIA: A PROSPECTIVE COHORT STUDY
23. A comparative study on clinical and serological characteristics between patients with rhupus and those with systemic lupus erythematosus and rheumatoid arthritis
24. AB0770 DESCRIBING A COHORT OF PATIENTS WITH PSORIATIC ARTHRITIS ACCORDING TO THE BODY MASS INDEX: EXPERIENCE IN A JOINT RHEUMATOLOGY-DERMATOLOGY CLINIC
25. AB0489 BETA 2 MICROGLOBULIN AS A PROGNOSTIC FACTOR IN CRYOGLOBULINEMIA NON ASSOCIATED WITH HEPATOTROPIC VIRUSES
26. FRI0594 USE OF ANTI-DFS70 ANTIBODIES IN RHEUMATOLOGICAL PATIENTS WITH SUSPICION OF SYSTEMIC AUTOIMMUNE DISEASE
27. SAT0217 PERFORMANCE OF ACR/EULAR 2019, SLICC 2012 AND ACR 1997 CLASSIFICATION CRITERIA IN A COHORT OF SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH LONGSTANDING DISEASE
28. FRI0442 APPROPRIATE USE OF SEROLOGY TESTS FOR THE DIAGNOSIS OF LYME DISEASE. EXPERIENCE IN AN URBAN AREA
29. SAT0314 To describe and characterise the patient group defined as complex in a joint rheumatology/dermatology clinic (PAIDER)
30. AB0579 Immunological results of salivary gland biopsy and their relationship with clinical and serological parameters in primary sjÖgren’s syndrome
31. FRI0197 Association of the electrocardiographic disturbances with aortic root dilation in patients with ankylosing spondylitis
32. ORDER OF APPEARANCE OF PSORIASIS AND ARTHRITIS SYMPTOMS IN PSORIATIC ARTHRITIS: COMPARATIVE STUDY OF A RETROSPECTIVE COHORT.
33. NAILFOLD CAPILLAROSCOPY FINDINGS IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES AND ITS ASSOCIATION TO AUTOANTIBODIES: A CASECONTROL STUDY.
34. NON-INFECTIOUS AORTITIS: CLINICAL AND HISTOLOGICAL CORRELATION.
35. HISTORY OF ABORTION AND MULTIPARITY IN SYSTEMIC AUTOIMMUNE DISEASES: RESULTS FROM A MULTIDISCIPLINARY PREGNANCY CLINIC (GYNECOLOGY, RHEUMATOLOGY AND NEPHROLOGY).
36. PREGNANCY IN AUTOIMMUNE DISEASES: THE IMPACT OF PREGNANCY PLANNING ON REPRODUCTIVE OUTCOMES IN A MULTIDISCIPLINARY PRECONCEPTION OUTPATIENT CLINIC.
37. EVALUATION OF SATISFACTION AND EFFICACY OF SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS BELIMUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN DAILY CLINICAL PRACTICE.
38. ASSOCIATION BETWEEN NAILFOLD VIDEOCAPILLAROSCOPY FINDINGS AND SKL-6 LEVELS IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES-RELATED INTERSTITIAL LUNG DISEASE.
39. Predictive factors for induction of remission in patients with active rheumatoid arthritis treated with tocilizumab in clinical practice
40. AB0717 Conduction disturbances in a group of patients with axial spondyloarthropathy
41. SAT0379 Nailfold capillaroscopy findings in patients with inflammatory myopathy and/or specific or associated antibodies
42. AB0948 Insufficient calcium intake in pediatric population with risk factors for osteoporosis
43. AB1027 The utility of lip biopsy in patients diagnosed of IPAF (interstitial pneumonia with autoimmune features)
44. FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors
45. BIOMARKERS IN JUVENILE IDIOPATIC ARTHRITIS: DESCRIPTION OF GROUPS WITH DIFFERENT DEGREES OF DISCREPANCY BETWEEN SERUM CALPROTECTIN AND C-REACTIVE PROTEIN.
46. DISEASE DURATION, AGE AND CLINICAL FEATURES RELATED TO AORTIC VALVE SCLEROSIS IN PATIENTS WITH SPONDYLOARTHRITIS.
47. TIME, DURATION AND ORDER OF APPEARANCE OF EXTRA-ARTICULAR MANIFESTATIONS IN SPONDYLARTHRITIS: CLINICAL RISK FACTORS.
48. DESCRIPTION AND PROGNOSTIC FACTORS FOR AORTITIS RELAPSE IN PATIENTS WITH GIANT CELL ARTERITIS.
49. CLINICAL FACTORS ASSOCIATED WITH VASCULAR COMPLICATIONS (ANEURYSMS, THROMBOSIS, DISSECTION OR SURGERY) IN PATIENTS WITH GIANT CELL ARTERITIS.
50. PREGNANCY IN SYSTEMIC LUPUS ERYTHEMATOSUS: DESCRIPTION AND COMPARISON OF COMORBIDITIES WITH OTHER SYSTEMIC AUTOIMMUNE DISEASES FROM A RHEUMATOLOGY PREGNANCY CLINIC.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.